Aristeia Capital’s Forbion European Acquisition Corp. Warrants FRBNW Stock Holding History

Aristeia Capital’s Portfolio FRBNW Stock Details FRBNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-39,798	Closed	-$29.8K	–	274
2023 Q3	$29.8K	Hold	39,798	–	–	﹤0.01%	153
2023 Q2	$17.6K	Sell	39,798 -32,600	-45%	-$11.7K	﹤0.01%	210
2023 Q1	$10.7K	Sell	72,398 -31,772	-31%	-$5.49K	﹤0.01%	352
2022 Q4	$18.4K	Hold	104,170	–	–	﹤0.01%	409
2022 Q3	$21K	Hold	104,170	–	–	﹤0.01%	574
2022 Q2	$13K	Hold	104,170	–	–	﹤0.01%	661
2022 Q1	$44K	Buy	+104,170	New	+$42.9K	﹤0.01%	657

Aristeia Capital's FRBNW Position: Q4 2023 in Review

Aristeia Capital sold out of Forbion European Acquisition Corp. Warrants (FRBNW) in Q4 2023, closing a stake of 39,798 shares — an estimated $29.8K sold.

Aristeia Capital first reported a position in FRBNW in Q1 2022 and held it in 7 quarters. The position peaked at $44K in Q1 2022. 0 funds tracked by Wall St. Rank hold FRBNW as of Q4 2023.

Aristeia Capital reported no remaining Forbion European Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Aristeia Capital sold 39,798 Forbion European Acquisition Corp. Warrants shares in Q4 2023, an estimated $29.8K.
Aristeia Capital first reported a position in Forbion European Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Aristeia Capital's Forbion European Acquisition Corp. Warrants position peaked at $44K in Q1 2022.
0 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Warrants as of Q4 2023.

Based on Aristeia Capital's 13F filing for Q4 2023, filed 14 Feb 2024.